For instance, siRNAs have been used in basic research as tools to knockdown expression of genes that are commonly mutated in MDS patients, such as ZRSR2 and antiapoptotic “survivin”, so as to better investigate their role in MDS pathophysiology [167,168]. Here, BIRC5 is linked to myelodysplastic syndrome.